We are live on
!
Find out more
CPH
C Partners Holding Portfolio holdings
AUM
$317M
1-Year Est. Return
4.76%
This Fund
S&P 500
This Quarter
Est. Return
-8.49%
1 Year Est. Return
-4.76%
3 Year Est. Return
+31.57%
5 Year Est. Return
+26.92%
10 Year Est. Return
+222.73%
AUM
$181M
AUM Growth
-$32.1M
(-15%)
Cap. Flow
-$8.44M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
83.13%
Holding
44
New
1
Increased
2
Reduced
1
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
+$29.5M |
| 2 |
Intercontinental Exchange
ICE
|
+$4.63M |
| 3 |
ExxonMobil
XOM
|
+$2.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADMS
Adamas Pharmaceuticals
ADMS
|
+$3.69M |
| 2 |
CELG
Celgene Corp
CELG
|
+$3.59M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.93M |
| 4 |
Viatris
VTRS
|
+$2.6M |
| 5 |
Abbott
ABT
|
+$2.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.24% |
| 2 | Materials | 6.04% |
| 3 | Consumer Staples | 5.29% |
| 4 | Financials | 5.23% |
| 5 | Industrials | 4.9% |
Similar funds
KI
CPW
GWP
TM
WIS
CC
FNWM
GBFG
C Partners Holding's Q3 2015 Portfolio in Review
As of Q3 2015, C Partners Holding held 44 positions worth $181M, down 15% from $213M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
C Partners Holding withdrew a net $8.44M in Q3 2015, closing 26 positions and reducing 1 holding. Its most notable exit was Celgene Corp, an estimated $3.59M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.2% of assets, up from 6.6% a quarter earlier, followed by Materials and Consumer Staples.
Against the trend, C Partners Holding opened a new position in Conformis, Inc. Common Stock worth $26.4M.
- C Partners Holding's largest Q3 2015 buy was Conformis, Inc. Common Stock: 58,506 shares worth $26.4M.
- C Partners Holding added most to Intercontinental Exchange in Q3 2015, an estimated $4.63M increase.
- C Partners Holding's biggest Q3 2015 reduction was Adamas Pharmaceuticals, cutting an estimated $3.69M.
- C Partners Holding fully exited Celgene Corp in Q3 2015, selling an estimated $3.59M.
- C Partners Holding's ten largest holdings make up 83% of its $181M portfolio in Q3 2015.
- C Partners Holding opened 1 new position and closed 26 in Q3 2015.
- C Partners Holding's portfolio value fell 15% quarter-over-quarter to $181M.
Based on C Partners Holding's 13F filing for Q3 2015, filed 12 Nov 2015.